HPβCD’s Promise in Treating Ischemic Stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
A forum for researchers, students and applicants in the field of cyclodextrin technology
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
The selective removal of trace heteroatomic contaminants from fuel remains a critical challenge for clean combustion and refinery upgrading, particularly
Natural antimicrobial peptides are a promising new class of antibiotics that offer a potential response to the growing challenge of
The adsorption of drugs and their carriers onto double-stranded DNA is potentially significant for their transport and release within cells,
In recent decades, the biomedical and pharmaceutical potential of cyclodextrins has expanded remarkably. Their well‑established host–guest complexation ability continues to
A Nanjing, China based research group designed a tailored investigation [1] based on a surprising previous study [2]. In they
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona
Hewlett-Packard has developed a multi-fluid kit for three-dimensional printing, comprising:– a fusing agent including: – an electromagnetic energy absorber; and
Several North-American Universities worked together to find hydroxzpropyl-alpha-cyclodextrin(HPaCD) for the treatment of Krabbe disease. The deficiency of β-galactosylceramidase causes a
The 11th Edition of Innovations in Food Science and Human Nutrition (IFHN-2026) conference is scheduled to take place on July
Phlorotannins have gained significant attention as functional supplements because of their potential bioactive and functional properties. Phlorotannins are, however, highly
Prof. Dr.-Ing. Wolfram Saenger passed away on 16 February 2026. He was a German biochemist and protein scientist renowned for
Cyclodextrins are commonly used as excipients in modern drug delivery, but they also have a less common role as active